Primary Research · 2022
Ashwagandha as a Unique Cause of Thyrotoxicosis Presenting with Supraventricular Tachycardia
Primary literature · Case report, 2022
Key finding
Patient presented with supraventricular tachycardia and biochemical thyrotoxicosis after two years of self-administered ashwagandha. Full symptomatic and biochemical resolution after cessation, with no other intervention.
Read the paper
Open sourcehttps://pmc.ncbi.nlm.nih.gov/articles/PMC9035336/
About this page
Formulate maintains a registry of clinical studies cited across its guides and evidence grades. This page links the study metadata to the content that cites it — one canonical entry per landmark study.
The full citation chain is public so readers can verify claims without hunting through individual guide pages. Browse all cited studies →
Note: Study summaries on this page are editorial interpretations of the research. Always consult the primary source before drawing clinical conclusions.